U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector transforms.

The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

Since 1994, the United States and its major trading partners have agreed to reciprocal tariff elimination for pharmaceutical ...

CFO Vanessa Kanu reported Q4 adjusted EBITDA of $195 million, representing a 9% increase year-over-year. She attributed the 27% increase in adjusted diluted EPS to strong margins and a lower tax rate ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

The investment case for Zhejiang Huahai, based within the province of Zhejiang, is that it is cheap based on current ...

Half a world away from Washington, Asia’s corporate titans are coming to grips with the new, or perhaps all too familiar, ...

55 The same month, Minister of Commerce Wang Wentao held a roundtable with foreign pharmaceutical company ... For instance, China’s potential inclusion in Project Orbis, a framework created by the U.S ...

Ansell has moved to expand its manufacturing presence beyond China, to countries including India and Sri Lanka.

Public health experts worry the FDA workforce will be slashed, impeding the ability of the agency to review new medicines ...